en · de · es · fr · pt
aod-9604-notes.peptides4800.com › Info › Identity And Research Background — Field Notes

Identity And Research Background — Field Notes

By Editorial Desk · published 2026-02-19 · last reviewed 2026-03-23 · Info

synthetic peptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-03-23. Anything still debated is marked as such rather than presented as settled.

Identity And Research Background

AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.

AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.

Identity and Research Origin

AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.

Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.

Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideFragment analog of human growth hormone
Sequence basishGH 176–191 regionModified C-terminal fragment
Common synonymsAOD-9604; AOD9604; hGH fragmentResearch and trade names vary
Regulatory statusNot approved as a drugProhibited in competitive sport
Research codeAOD9604Used in scientific and patent literature

Background from the literature

Fifteen minutes later Faith 7 landed just four miles (6 km) from the prime recovery ship, the carrier USS Kearsarge. This was the most accurate landing to date, despite the lack of automatic controls. Faith 7 landed 70 nautical miles (130 km) southeast of Midway Island, in the Pacific Ocean. This would be near 27°30′N 176°15′W. Splashdown was at 34 hours 19 minutes 49 seconds after liftoff. The spacecraft tipped over in the water momentarily, then righted itself. Helicopters dropped rescue swimmers and relayed Cooper's request of an Air Force officer for permission to be hoisted aboard the Navy's carrier. Permission was granted. Forty minutes later the explosive hatch blew open on the deck of Kearsarge. Cooper stepped out of Faith 7 to a warm greeting.

== In popular culture == The 1990 film Reversal of Fortune depicts the case and its surrounding fallout. For his portrayal of Claus von Bülow, Jeremy Irons won the Academy Award for Best Actor. Klaus and Sunny Baudelaire from A Series of Unfortunate Events are named after Claus and Sunny von Bülow.

Noted for his longevity in the game, Fletcher played a total of 400 senior VFL/AFL games, which stands as the fifth-highest number of games by any player as of 2023. His AFL career length of 22 years and 58 days is an all-time league record (edging out Vic Cumberland, whose former record was five days shy of 22 years). Fletcher played his 400th game in Round 9, 2015, becoming the third player in VFL/AFL history to reach the milestone (after Michael Tuck and Kevin Bartlett); it would end up being his final game, as he was unable to recover from a groin injury sustained during the match. He holds the outright Essendon games record, having overtaken the previous record of 378 games held by Simon Madden in Round 1, 2014. He is the second-oldest player to play a VFL/AFL game, aged 40 years and 23 days at the time of his final game, behind only the aforementioned Vic Cumberland (who played the 1920 season at the age of 43). With his father, Ken, the Fletchers hold the record for the most VFL/AFL career games played by a father and son, with 664 games between them. On 12 January 2016, during the summer after his retirement, Fletcher was named as one of 34 past and present Essendon players found guilty over their use of illegal supplements during the 2012 AFL season. As a result, Fletcher was suspended from playing at all levels for 24 months, which with backdating and provisional suspension served resulted in suspension until November 2016. However, Fletcher had already retired the previous year, so the suspension was moot.

Sources: en.wikipedia.org

Related pages on this site

Further detail

The process for class 1 inteins begins with an N-O or N-S shift when the side chain of the first residue (a serine, threonine, or cysteine) of the intein portion of the precursor protein nucleophilically attacks the peptide bond of the residue immediately upstream (that is, the final residue of the N-extein) to form a linear ester (or thioester) intermediate. A transesterification occurs when the side chain of the first residue of the C-extein attacks the newly formed (thio)ester to free the N-terminal end of the intein. This forms a branched intermediate in which the N-extein and C-extein are attached, albeit not through a peptide bond. The last residue of the intein is always an asparagine (Asn), and the amide nitrogen atom of this side chain cleaves apart the peptide bond between the intein and the C-extein, resulting in a free intein segment with a terminal cyclic imide. Finally, the free amino group of the C-extein now attacks the (thio)ester linking the N- and C-exteins together. An O-N or S-N shift produces a peptide bond and the functional, ligated protein. Class 2 inteins have no nucleophilic first side chain, only an alanine. Instead, the reaction starts directly with a nucleophilic displacement, with the first residue of the C-extein attacking the peptide carboxyl on the final residue of the N-extein. The rest proceeds as usual, starting with Asn turning into a cyclic imide. Class 3 inteins have no nucleophilic first side chain, only an alanine, yet they have an internal noncontiguous "WCT" motif.

=== Signs === There are many different signs of dehydration in undernourished people. These can include sunken eyes; a very dry mouth; decreased urine output or dark urine; increased heart rate with decreasing blood pressure; and altered mental status.

Scottish families of the names Bruce, Gray, Ramsay, Fraser, Rose, Ogilvie, Montgomery, Sinclair, Pollock, Burnard, Douglas and Gordon to name but a few, and including the later royal House of Stewart, can all be traced back to Norman ancestry.

==== Dietary recommendations ==== In the UK, the recommended daily values by the Dietary Reference Intake for magnesium are 300 mg for men and 270 mg for women. In the U.S. the Recommended Dietary Allowances (RDAs) are 400 mg for men ages 19–30 and 420 mg for older; for women 310 mg for ages 19–30 and 320 mg for older.

Sources: en.wikipedia.org

Supporting material

Officially, Portugal has 13 national, government-recognised holidays. Public holidays in Portugal are regulated by the Labour Code. Besides the national holidays, there are regional holidays celebrated only in Madeira and the Azores and two facultative holidays which are the Entrudo and one municipal holiday allowed per concelho. Unlike some official holidays, Portugal's folk festivities remain widely attended and are rooted in local traditions, such as the Carnival of Ovar, Lisbon's Marchas Populares, and Porto's Festa de São João. Many of folk festivities are associated with the Santos Populares, Christian celebrations with older pagan origins linked to Midsummer. These festivities are celebrated across the country, especially in rural areas, and typically include music performances, stages, temporary arenas, and traditional food stalls.

The confirmation test in most laboratories (and all SAMHSA certified labs) is performed using mass spectrometry, and is precise but expensive. False positive samples from the screening test will almost always be negative on the confirmation test. Samples testing positive during both screening and confirmation tests are reported as positive to the entity that ordered the test. Most laboratories save positive samples for some period of months or years in the event of a disputed result or lawsuit. For workplace drug testing, a positive result is generally not confirmed without a review by a Medical Review Officer who will normally interview the subject of the drug test.

=== Inapplicability of impact factor to individuals and between-discipline differences === It has been stated that impact factors in particular and citation analysis in general are affected by field-dependent factors which invalidate comparisons not only across disciplines but even within different fields of research of one discipline. The percentage of total citations occurring in the first two years after publication also varies highly among disciplines from 1–3% in the mathematical and physical sciences to 5–8% in the biological sciences. Thus impact factors cannot be used to compare journals across disciplines. Impact factors are sometimes used to evaluate not only the journals but the papers therein, thereby devaluing papers in certain subjects. In 2004, the Higher Education Funding Council for England was urged by the House of Commons Science and Technology Select Committee to remind Research Assessment Exercise panels that they are obliged to assess the quality of the content of individual articles, not the reputation of the journal in which they are published. Other studies have repeatedly stated that impact factor is a metric for journals and should not be used to assess individual researchers or institutions.

== Further reading == Press Conference by professor Samuel S. Epstein M.D. 1999-05-31 World Trade Organization (2000). Dispute Settlement Reports 1998. Cambridge University Press. p. 79. ISBN 0-521-78895-1. Galbraith, H. (December 2002). "Hormones in international meat production: biological, sociological and consumer issues". Nutrition Research Reviews. 15 (2). CABI Publishing: 293–314. doi:10.1079/NRR200246. PMID 19087409. M. Ellin Doyle. "Human Safety of Hormone Implants Used to Promote Growth in Cattle". National Cattlemen's Foundation. Archived from the original (Microsoft Word) on 7 May 2006. J. J. Kastner & R. K. Pawsey (29 November 2001). "Harmonising sanitary measures and resolving trade disputes through the WTO–SPS framework. Part I: a case study of the US–EU hormone-treated beef dispute" (PDF). Food Control. 13. Elsevier Science Ltd.: 49–55. doi:10.1016/S0956-7135(01)00023-8. Archived from the original (PDF) on 21 May 2004. Tim Josling; Donna Roberts & Ayesha Hassan (12 April 2000). "The Beef-Hormone Dispute and its Implications for Trade Policy" (PDF). Stanford University. Archived from the original (PDF) on 11 June 2007. Grace Skogstad (September 2001). "The WTO and Food Safety Regulatory Policy Innovation in the European Union". Journal of Common Market Studies. 39 (3): 485–505. doi:10.1111/1468-5965.00300. Christina L. Davis (2003). "Battles over Beef: The Beef Hormone Dispute". Food Fights Over Free Trade: How International Institutions Promote Agricultural Trade Liberalization. Princeton University Press. pp. 321–337. ISBN 0-691-11505-2.

=== Life expectancy === The life expectancy in Bromley Town ward (which covers the town centre) was 79.3 years for males and 83.7 years for females, during 2009–2013. The highest in the town were in Shortlands: 86.1 years for males and 88.1 years for females. The lowest for both genders was in Plaistow and Sundridge: 77.5 and 82.1 years respectively.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 the same as human growth hormone?

No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.

Was AOD-9604 approved for weight loss?

It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.

Why is AOD-9604 banned in sports?

WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.

Network